Endothelial protein C receptor supports hematopoietic stem cell engraftment and expansion in Mpl-deficient mice.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
28 03 2019
Historique:
received: 09 03 2018
accepted: 15 01 2019
pubmed: 27 1 2019
medline: 4 12 2019
entrez: 27 1 2019
Statut: ppublish

Résumé

Thrombopoietin (Thpo)/myeloproliferative leukemia virus oncogene (Mpl) signaling controls hematopoietic stem cell (HSC) self-renewal and quiescence; however, how these 2 seemingly opposing functions are controlled is not well understood. By transplantation of lentiviral-transduced hematopoietic cells in the Mpl-deficient mouse model, we addressed whether known or predicted Thpo target genes were able to rescue the Mpl-deficient phenotype of the mice. Among the tested genes, we identified endothelial protein C receptor (Epcr) to expand HSCs with the long-term (LT)-HSC surface phenotype in Mpl

Identifiants

pubmed: 30683655
pii: S0006-4971(20)42669-2
doi: 10.1182/blood-2018-03-837344
doi:

Substances chimiques

Endothelial Protein C Receptor 0
Mpl protein, mouse 0
Procr protein, mouse 0
Receptors, Thrombopoietin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1465-1478

Informations de copyright

© 2019 by The American Society of Hematology.

Auteurs

Saskia Kohlscheen (S)

Research Group for Gene Modification in Stem Cells, Division of Veterinary Medicine, Paul Ehrlich Institute, Langen, Germany.

Franziska Schenk (F)

Research Group for Gene Modification in Stem Cells, Division of Veterinary Medicine, Paul Ehrlich Institute, Langen, Germany.

Marcel G E Rommel (MGE)

Research Group for Gene Modification in Stem Cells, Division of Veterinary Medicine, Paul Ehrlich Institute, Langen, Germany.

Katharina Cullmann (K)

Research Group for Gene Modification in Stem Cells, Division of Veterinary Medicine, Paul Ehrlich Institute, Langen, Germany.

Ute Modlich (U)

Research Group for Gene Modification in Stem Cells, Division of Veterinary Medicine, Paul Ehrlich Institute, Langen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH